Benzinga | Jan 29, 2021 11:47AM EST

Rigel Pharmaceuticals Awarded $16.5M Contract To Support Phase III Clinical Trial Using Fostamatinib Against COVID-18

https://www.jpeocbrnd.osd.mil/news/news-story/2021/01/29/dod-supports-phase-iii-clinical-trial-using-fostamatinib-(tavalisse-)-against-covid-19